Poseida Therapeutics

YTD

ALL

Why Robinhood?

You can watch PSTX and buy or sell other stocks, ETFs, and their options commission-free!

About PSTX

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T.

CEO

Kristin Yarema, PhD

CEOKristin Yarema, PhD

Employees

—

Employees—

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2014

Founded2014

Employees

—

Employees—

PSTX Key Statistics

Market cap

925.41M

Market cap925.41M

Price-Earnings ratio

-15.00

Price-Earnings ratio-15.00

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$9.67

52 Week high$9.67

52 Week low

$2.32

52 Week low$2.32

People also own

Based on the portfolios of people who own PSTX. This list is generated using Robinhood data, and it’s not a recommendation.